Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Autologous Stem Cell Transplantation With CD34-Selected Peripheral Blood Stem Cells (PBSC) in Patients With Treatment Resistant Systemic Sclerosis (SSc)

NCT03630211 is registered in ClinicalTrials.gov with Paul Szabolcs as lead sponsor.

NCT NCT03630211
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03630211 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Autologous Stem Cell Transplantation With CD34-Selected Peripheral Blood Stem Cells (PBSC) in Patients With Treatment Resistant Systemic Sclerosis (SSc)
Lead sponsor
Paul Szabolcs
Phase
Phase 2
Overall status
Recruiting
Start date
July 31, 2018
Completion date
August 1, 2028
Enrollment
8 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse sclerosis systemic, interstitial lung disease, pulmonary hypertension, systemic sclerosis